Clinical significance of basal-like subtype in triple-negative breast cancer
作者： Yutaka Yamamoto , Mutsuko Ibusuki , Masahiro Nakano , Teru Kawasoe , Ryousuke Hiki
DOI: 10.1007/S12282-009-0150-8
关键词: Cancer 、 Progesterone receptor 、 Breast cancer 、 Estrogen receptor 、 Medicine 、 Triple-negative breast cancer 、 Oncology 、 Clinical significance 、 Surgical oncology 、 Basal (phylogenetics) 、 Internal medicine
摘要: Background No clinically useful target molecule has been identified for triple-negative (TN) breast cancer, i.e., estrogen receptor (ER)-negative, progesterone (PgR)-negative, human epidermal growth factor receptor-2 (HER2)-negative phenotype, and its prognosis is poor. Triple-negative cancer consists of two subtypes: basal-like non-basal-like. The aim this study to clarify the clinical biological characteristics these subtypes TN cancer.
springer.com
sci-hub.se 参考文章(37)
Frédérique Spyratos, Magali Ferrero-Poüs, Martine Trassard, Kamel Hacène, Edelmira Phillips, Michèle Tubiana-Hulin, Viviane Le Doussal, Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Cancer. ,vol. 94, pp. 2151- 2159 ,(2002) , 10.1002/CNCR.10458
Hongyi Zhou, Jian Kuang, Ling Zhong, Wen-lin Kuo, Joe Gray, Aysegul Sahin, Bill Brinkley, Subrata Sen, Tumour amplified kinase STK15 / BTAK induces centrosome amplification, aneuploidy and transformation Nature Genetics. ,vol. 20, pp. 189- 193 ,(1998) , 10.1038/2496
Gloria J. Morris, Sashi Naidu, Allan K. Topham, Fran Guiles, Yihuan Xu, Peter McCue, Gordon F. Schwartz, Pauline K. Park, Anne L. Rosenberg, Kristin Brill, Edith P. Mitchell, Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. ,vol. 110, pp. 876- 884 ,(2007) , 10.1002/CNCR.22836
JS Reis‐Filho, ANJ Tutt, None, Triple negative tumours : a critical review Histopathology. ,vol. 52, pp. 108- 118 ,(2007) , 10.1111/J.1365-2559.2007.02889.X
Melanie E. Royce, Weiya Xia, Aysegul A. Sahin, Hiroshi Katayama, Dennis A. Johnston, Gabriel Hortobagyi, Subrata Sen, Mien-Chie Hung, STK15/Aurora-A Expression in Primary Breast Tumors Is Correlated with Nuclear Grade but Not with Prognosis Cancer. ,vol. 100, pp. 12- 19 ,(2004) , 10.1002/CNCR.11879
P. G. Natali, M. R. Nicotra, I. Sures, M. Mottolese, C. Botti, A. Ullrich, Breast cancer is associated with loss of the c-kit oncogene product. International Journal of Cancer. ,vol. 52, pp. 713- 717 ,(1992) , 10.1002/IJC.2910520508
Aron Goldhirsch, William C. Wood, Richard D. Gelber, Alan S. Coates, Beat Thürlimann, Hans-Jörg Senn, Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer Journal of Clinical Oncology. ,vol. 21, pp. 3357- 3365 ,(2003) , 10.1200/JCO.2003.04.576
Emad A. Rakha, Maysa E. El-Sayed, Andrew R. Green, Andrew H. S. Lee, John F. Robertson, Ian O. Ellis, Prognostic markers in triple-negative breast cancer Cancer. ,vol. 109, pp. 25- 32 ,(2007) , 10.1002/CNCR.22381
Katrina R. Bauer, Monica Brown, Rosemary D. Cress, Carol A. Parise, Vincent Caggiano, Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. ,vol. 109, pp. 1721- 1728 ,(2007) , 10.1002/CNCR.22618
Irina Matos, Rozany Dufloth, Marcelo Alvarenga, Luiz Carlos Zeferino, Fernando Schmitt, p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Archiv. ,vol. 447, pp. 688- 694 ,(2005) , 10.1007/S00428-005-0010-7